Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | January 30, 2013

Alzheimer’s, ALS and Concussions: Connecting the Dots

In what one day may be recognized as a melding of epidemiology and medical imaging, researchers are associating human conditions once viewed as unavoidable or natural consequences of American life as diseases with commonalities that can be seen and measured in the living brain. It is a transformation I have lived through from the beginning, remembering how my grandmother’s senility was viewed as an inevitable consequence of age; how those rooted in that perception mispronounced Alzheimer’s disease as “old timer’s disease;” how coaches — and parents — joked about high school players getting their “bells rung” in football; and how those impacts are now viewed as concussions.

In September it was reported in the peer reviewed journal Neurology that pro football players may have up to four times higher risk of death from Alzheimer's and Lou Gehrig's disease (ALS). Last week the American Journal of Geriatric Psychiatry published medical images online showing proteins, called tau proteins, often found in elderly patients with Alzheimer’s disease but in this case present in the brains of living NFL players (“Study First to Image Concussion-Related Abnormal Brain Proteins in Retired NFL Players,” http://www.itnonline.com/article/study-first-image-concussion-related-abnormal-brain-proteins-retired-nfl-players). Previous studies had shown that pro athletes in contact sports are at risk of developing chronic traumatic encephalopathy (CTE), a degenerative condition associated with accumulation of tau protein.

Brick by metaphorical brick, researchers are building a road to understanding brain disease and medical imaging is lighting the way. University of California, Los Angeles (UCLA) researchers used a positron emission tomography (PET) biomarker, 18F-FDDNP (2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile), which binds to deposits of amyloid plaques and neurofibrillary tau tangles, the hallmarks of Alzheimer’s disease, to look at the brains of NFL players. Compared to healthy control subjects, these athletes had elevated levels of FDDNP in the amygdala and subcortical regions of the brain, regions that control learning, memory, behavior and emotions. Players who had more concussions had higher 18F-FDDNP levels on PET scans.

The connection between football and the risk of death due to neurodegenerative disease came from a study by the National Institute for Occupational Safety and Health (NIOSH) in Cincinnati, published online in Neurology (http://www.neurology.org/content/early/2012/09/05/WNL.0b013e31826daf50.abstract), which looked at 3,439 NFL players. Of the 334 who died, seven had Alzheimer's disease and seven had ALS — four times the rate for the general population.

“While CTE is a separate diagnosis, the symptoms are often similar to those found in Alzheimer's, Parkinson's and ALS, and can occur as the result of multiple concussions," said Everett J. Lehman, author of the NIOSH study.

The work by NIOSH and UCLA researchers so far has limited practical application. It is aimed at understanding what is happening in the brains of injured athletes and whether those changes share an etiology with neurodegenerative diseases. Through their research, however, may come the means that allow early detection of disease before symptoms occur and possibly the means to prevent those diseases altogether. 

Some of this understanding may come from processes developed more than a century ago by John Snow, M.D., the father of epidemiology. In the mid-1800s, Snow hypothesized that polluted water containing a poison that had the ability “to multiply itself by a kind of growth” in the digestive tract was the underlying cause of cholera. This ran counter to the accepted belief that cholera was due to noxious gases, called miasmas. Snow traced cholera outbreaks in London to polluted wells by meticulously linking victims to where they lived and what they did. Snow died not knowing that the poison he hypothesized was a bacillus, Vibrio cholera, isolated and cultured in 1884 by Robert Koch. 

Today researchers are pursuing tau protein to better understand what is happening in the brains of injured athletes, having visualized its existence with PET in their brains and those of patients with diseases presenting with similar symptoms.

Who knows where it will lead.

Related Content

GE Healthcare unveiled Revolution Ascend with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to deliver more personalized care to more patients.
News | Computed Tomography (CT) | September 27, 2021
September 27, 2021 — GE Heal
Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software for the medical sector – launched E-shop: the new online store to reach medical professionals more quickly and effectively.
News | Radiology Business | September 27, 2021
September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector –...

Image courtesy of Ziehm

News | Mobile C-Arms | September 27, 2021
September 27, 2021 — According to the statistics by the World Health O...
Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021
September 23, 2021 — GE has entered into an
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy.

Semi-automatic lesion identification: (A) Manual ROI indication. In blue, it is possible to observe the axes that cross the lesion manually delineated by the radiologist on a plane of the MPR. The intensity of the lesion boundary (estimated) is represented with a red outline. (B) Additional axes can be dragged onto other orthogonal MPR views. From left to right, it is possible to observe the initial long axis outlined by the radiologist and the 2D contours on the axial, coronal and sagittal views of the lesion used as a starting point for the RPM algorithms. (C) Resulting 3D contour of the lesion (in blue).

News | Radiomics | September 21, 2021
September 21, 2021 —  HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed ...
News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...